Special Allocation Scheme · UK public procurement notice

The Health Care Services (Provider Selection Regime) Regulations 2023, Paragraph 10 - The Most Suitable Provider Process is being used to commission this service. This notice will be live for fourteen (14) days from the date of publication.

This is a notice to inform the market of the intention to award a contract for a Special Allocation Scheme for the population of Nottingham and Nottinghamshire.

The service provides patients that have been subject to an immediate removal from a GP's patient list on the grounds of violence or threatening behaviour, continued access to essential, additional and enhanced primary medical services within a secure environment.

The Provider should be able to evidence:

Integration within Nottingham and Nottinghamshire, with established premises and access to security if risk assessment identifies the need.

Delivery of a service that adheres to the National Health Service (General Medical Services Contracts and Personal Medical Services Agreements) Regulations 2015 (updated) and the Primary Medical Care Policy and Guidance Manual (PGM) Section 7.

Able to deliver the service in line with core GP contract requirements, access during the hours of 8am-6:30pm, Monday to Friday, excluding bank holidays. This will include face to face, virtual and telephone consultations. All patients requesting an appointment can expect to receive one within a clinically appropriate and reasonable time.

Robust relationships with Primary and Secondary Care, Community Services and the Mental Health Trust to enable onward referral and support to patients for rehabilitation.

Registered with CQC.

All GPs employed are registered with General Medical Council (GMC) and on the National Performers List.

Engage in continuous improvement activities, using quality improvement tools and evidence to enhance care delivery.

Operate an effective comprehensive System of Clinical Governance with clear channels of accountability, supervision and effective systems to reduce the risk of clinical system failure.

The estimated value and length of the contract is £143,500 per annum (£717,500) for 4 years.